The Changes of Brain-gut SP and VIP Levels in the Rats with Functional Dyspepsia and the Intervention of Pingwei Capsule
Open Access
- 1 January 2018
- journal article
- Published by ACT Publishing Group in Journal of Gastroenterology and Hepatology Research
- Vol. 7 (1) , 2521-2529
Abstract
AIM: To explore the levels of substance P (SP) and vasoactive intestinal peptide (VIP) in the brain–gut axis of rats with functional dyspepsia (FD) and the intervention of Pingwei capsule. METHODS: FD model rats were established by stimulating semi-starved rats via tail damping, provocation, and forced exercise fatigue. Then, the rats were treated with domperidone and Traditional Chinese Medicine, Pingwei capsule, for 3 weeks.The rates of the rat intestinal propulsion and gastric emptying were observed and the levels of SP and VIP were detected in serum by the enzyme-linked immunosorbent assay(ELISA), and in antrum, duodenum and hypothalamus by reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry. RESULTS: FD rats were less active, nervous, anxious and dysphoria, loose stool was observed, the bodyweight and food intake decreased obviously, and their intestinal propulsion and gastric emptying slowed down markedly. Molecular biological experiments showed that the mRNA and protein expressions of SP and VIP increased significantly in antrum, duodenum, and hypothalamus of FD rats, but the SP level markedly decreased in serum compared with that in the control group. Domperidone and Pingwei capsule could improve the behavioral performances and intestinal propulsion and gastric emptying , and decrease the expressions of SP and VIP in brain–gut axis of FD rats. CONCLUSION: There appear abnormal behaviors, dysmotility gastrointestinal disorders and parasecretion of brain-gut SP and VIP in FD rats. Similarity to domperidone, Pingwei capsule has a degree of therapeutic effects in rats with FD.Keywords
This publication has 12 references indexed in Scilit:
- Influence of a neurokinin‐1 receptor antagonist (aprepitant) on gastric sensorimotor function in healthy volunteersNeurogastroenterology & Motility, 2013
- An antinociceptive role for substance P in acid-induced chronic muscle painProceedings of the National Academy of Sciences, 2011
- Relation Between Clinical Symptoms and Experimental Visceral Hypersensitivity in Pediatric Patients With Functional Abdominal PainJournal of Pediatric Gastroenterology and Nutrition, 2008
- Peripheral and central mechanisms of visceral sensitization in manNeurogastroenterology & Motility, 2007
- Role of vasoactive intestinal peptide and nitric oxide in the modulation of electroacupucture on gastric motility in stressed ratsWorld Journal of Gastroenterology, 2006
- Novel Evidence for Hypersensitivity of Visceral Sensory Neural Circuitry in Irritable Bowel Syndrome PatientsGastroenterology, 2006
- Effect of qi-regulating Chinese medicine on gastrointestinal motilityWorld Chinese Journal of Digestology, 2004
- Symptoms associated with hypersensitivity to gastric distention in functional dyspepsiaGastroenterology, 2001
- Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controlsGut, 2000
- The Etiologic Role of Gastric Hypersensitivity in Functional Dyspepsia in KoreaJournal of Clinical Gastroenterology, 1999